Clinical Trials Directory

Trials / Completed

CompletedNCT04780230

Non-invasive Brain Stimulation to Enhance Treatment of Dysarthria Post-stroke

Modulation of Primary Motor Cortex to Enhance Treatment of Dysarthria Post-stroke

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
The Hong Kong Polytechnic University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The proposed study aims to determine if transcranial direct current stimulation can enhance the effect of speech therapy in post-stroke patients with dysarthria.

Detailed description

A total of 60 Cantonese-speaking post-stroke patients who are suffering from dysarthria will be recruited and randomly divided into real tDCS and sham groups. All the participants will receive individualized speech therapy based on the results of their speech assessment. For the real tDCS group, an anodal high-definition tDCS of 2 milliamperes (mA) lasting for 20 minutes will be delivered to the orofacial area of the primary motor cortex (SM1) during speech therapy. For the sham tDCS group, stimulation given during speech therapy will only last for 30 seconds in order to cause a similar sensation on the scalp as the real stimulation group. There will be a total of 10 daily sessions during a 2-week period.

Conditions

Interventions

TypeNameDescription
DEVICEtDCS activeAn anodal high-definition tDCS of 2 mA lasting for 20 minutes will be delivered to the orofacial area of the primary motor cortex (SM1) during speech therapy.
DEVICEtDCS shamAn anodal high-definition tDCS of 2 mA lasting for 30 seconds will be delivered to the orofacial area of the primary motor cortex (SM1) during speech therapy.

Timeline

Start date
2020-12-21
Primary completion
2023-11-30
Completion
2023-11-30
First posted
2021-03-03
Last updated
2024-01-18

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT04780230. Inclusion in this directory is not an endorsement.